BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19740432)

  • 1. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.
    Qiu FM; Yu JK; Chen YD; Jin QF; Sui MH; Huang J
    J Exp Clin Cancer Res; 2009 Sep; 28(1):126. PubMed ID: 19740432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Lim JY; Cho JY; Paik YH; Chang YS; Kim HG
    Int J Biol Markers; 2007; 22(4):281-6. PubMed ID: 18161659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
    Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
    Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum biomarker screening for the diagnosis of early gastric cancer using SELDI-TOF-MS.
    Li P; Zhang D; Guo C
    Mol Med Rep; 2012 Jun; 5(6):1531-5. PubMed ID: 22427025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of gastric cancer using decision tree classification of mass spectral data.
    Su Y; Shen J; Qian H; Ma H; Ji J; Ma H; Ma L; Zhang W; Meng L; Li Z; Wu J; Jin G; Zhang J; Shou C
    Cancer Sci; 2007 Jan; 98(1):37-43. PubMed ID: 17052262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
    Lim JB; Chung HW
    Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
    Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
    Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
    Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
    Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
    Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
    Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry.
    Liang Y; Fang M; Li J; Liu CB; Rudd JA; Kung HF; Yew DT
    Exp Mol Pathol; 2006 Oct; 81(2):176-80. PubMed ID: 16828742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer.
    Xu X; Wei S; Chen Y; Yu D; Wang X; Dong X
    Dis Markers; 2020; 2020():8493796. PubMed ID: 32908616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
    Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
    J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
    Yin LK; Sun XQ; Mou DZ
    Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma.
    Liu C; Pan C; Wang H; Yong L
    Tumour Biol; 2011 Dec; 32(6):1139-45. PubMed ID: 21826475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
    Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
    Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.